| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055525 Aminosulfonyl- or alkylsulfonylphenyl-heterocyclylalkylhydroxyamic acid or hydroxyurea derivatives; treating asthma and arthritis |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055181 Light generating compound for use in the detection of preferential particles in sample |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202981A1 Substituted heteroaryloxyacetanilides and their use as herbicides |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202979A1 Process for the preparation of thiazole derivatives |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/08/2002 | CN1084330C Cydic amide derivatives |
| 05/08/2002 | CA2361226A1 Process for the production of dithiazolyl disulfides |
| 05/07/2002 | US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b |
| 05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384065 Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same |
| 05/07/2002 | US6384062 Pharmaceutical composition |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
| 05/07/2002 | CA2052263C Herbicides |
| 05/02/2002 | WO2002034734A1 Process for the manufacture of thiazole derivatives with pesticidal activity |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2002034265A1 Use of 2-hydrazino-1,3-thiazoles as antioxidants |
| 05/02/2002 | WO2002034243A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2002034242A2 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 05/02/2002 | US20020052401 Benzophenones and sulfones as inhibitors of glycine uptake |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| 05/02/2002 | EP1201666A2 Epothilones with a modified side chain |
| 05/02/2002 | EP1201662A1 Preparation of thiazoles |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 05/02/2002 | EP1200420A1 Process for making n-alkyl bis(thiazolyl)sulfenimides |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200418A1 Nematicidal trifluorobutenes |
| 05/02/2002 | EP1200411A2 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | DE10052590A1 Verwendung von 2-Hydrazino-1,3-thiazolen als Antioxidantien Use of 2-hydrazino-1,3-thiazoles as antioxidants |
| 05/02/2002 | CA2689012A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | CA2424475A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/01/2002 | CN1083715C Use of insulin sensitisers for treating renal diseases |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380229 Useful for therapy and prophylaxis of hyperlipidemia and related complications |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380213 Compounds useful as neuro-protective agents |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380190 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/30/2002 | US6380187 Fungicides |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032889A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | WO2002032886A1 A process for the preparation of bis-benzazolyl compounds |
| 04/25/2002 | WO2002032883A1 Novel 4-benzyloxyphenyl derivative and use thereof |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032844A2 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
| 04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/25/2002 | US20020049316 Protease inhibitors |
| 04/25/2002 | US20020049241 Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents |
| 04/25/2002 | US20020049240 Novel compounds |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049228 2-Sulfamoylbenzoic acid derivatives |
| 04/25/2002 | US20020049215 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
| 04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
| 04/25/2002 | US20020049165 Inhibiting the enzymatic activity of HIV protease |
| 04/25/2002 | CA2426148A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 04/25/2002 | CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | CA2324194A1 Novel antifungal agents |
| 04/24/2002 | EP1199306A1 Biarylurea derivatives |
| 04/24/2002 | EP1198451A2 Substituted phenoxyacetic acids |
| 04/24/2002 | EP0830353B1 Process for the preparation of an hiv protease inhibiting compound |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |